Name of License: Notice of Intent to Grant Exclusive License
Summary: Notice is hereby given that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to Crysalis Biosciences, Inc. of Columbus, Georgia, an exclusive license to U.S. Patent No. 10,351,889, “METHODS AND STRAINS FOR PRODUCING BIOPRODUCTS IN AUREOBASIDIUM PULLULANS,” issued on July 16, 2019, and U.S. Patent No. 10,612,063, “METHODS AND STRAINS FOR PRODUCING BIOPRODUCTS IN AUREOBASIDIUM PULLULANS,” issued on April 7, 2020, both claiming priority to U.S. Provisional Patent Application No. 62/193,875, “METHODS AND STRAINS FOR PRODUCING BIOPRODUCTS IN AUREOBASIDIUM PULLULANS,” filed on July 17, 2015.
Tech Name:
METHODS AND STRAINS FOR PRODUCING BIOPRODUCTS IN AUREOBASIDIUM PULLULANS
Action: Notice of Intent.
Dates: Comments must be received on or before May 3, 2024.
Address: Send comments to: Diana D. Halsey, Business Licensing Officer, USDA, ARS, Office of Technology Transfer, 301-785-2741, [email protected].
For Further Information Contact: Diana D. Halsey, Business Licensing Officer, USDA, ARS, Office of Technology Transfer, 301-785-2741, [email protected].
Supplementary Information: The Federal Government's patent rights in these inventions are assigned to the United States of America, as represented by the Secretary of Agriculture. It is in the public interest to so license these inventions as Crysalis Biosciences, Inc. of Columbus, Georgia has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within thirty (30) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.